Article Information
History
- November 24, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jessica E. Agius1,2,3,#,†,
- Jessica C. Johnson-Mackinnon1,2,3,#,
- Winkie Fong1,2,
- Mailie Gall3,4,
- Connie Lam1,
- Kerri M. Basile4,
- Jen Kok1,4,
- Alicia Arnott1,3,4,
- Vitali Sintchenko1,2,3,4,* and
- Rebecca J. Rockett1,2,3,*
- 1Centre for Infectious Diseases and Microbiology - Public Health, Institute for Clinical Pathology and Medical Research Westmead Hospital, Westmead, NSW, Australia
- 2Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
- 3Sydney Institute for Infectious Diseases, Westmead Institute for Medical Research, Westmead, NSW, Australia
- 4Centre for Infectious Diseases and Microbiology Laboratory Services, Institute for Clinical Pathology and Medical Research, NSW Health Pathology, Sydney, NSW, Australia
- ↵†Corresponding author:
Dr Jessica Johnson-Mackinnon, Jessica.JohnsonMackinnon{at}health.nsw.gov.au, Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Westmead Hospital Westmead, NSW, 2145, Australia. +612 8890 6255
Posted November 24, 2021.
SARS-CoV-2 within-host and in-vitro genomic variability and sub-genomic RNA levels indicate differences in viral expression between clinical and in-vitro cohorts
